What is the definition of tertiary hyperparathyroidism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definition of Tertiary Hyperparathyroidism

Tertiary hyperparathyroidism is characterized by a lack of PTH suppression despite rising serum calcium levels, manifesting as hypercalcemic hyperparathyroidism that occurs in patients with long-standing secondary hyperparathyroidism. 1

Key Characteristics

  • Tertiary hyperparathyroidism (THPT) develops when parathyroid glands continue to oversecrete parathyroid hormone (PTH) autonomously after longstanding secondary hyperparathyroidism, despite normalization or elevation of serum calcium levels 2

  • It is most commonly encountered following kidney transplantation in patients with long-standing chronic kidney disease 1, 3

  • The condition represents a transition from an appropriate compensatory mechanism (secondary hyperparathyroidism) to autonomous parathyroid function that persists despite resolution of the original stimulus 4

Pathophysiology

  • Long-standing chronic kidney disease (CKD) causes metabolic disturbances including hyperphosphatemia, calcitriol deficiency, and hypocalcemia that lead to increased PTH secretion 2

  • Prolonged hypocalcemia and hyperphosphatemia cause parathyroid chief cell hyperplasia and excess PTH production 2

  • After correction of the primary disorder (typically through kidney transplantation), the hypertrophied parathyroid tissue fails to resolve and continues to oversecrete PTH despite normal or elevated calcium levels 2, 3

Pathologic Features

  • Marked parathyroid hyperplasia is the predominant morphologic feature (95% of cases), with 10-40 fold increases in parathyroid mass 5

  • Histologically, there is a predominance of chief cells and an abundance of oxyphil cells 5

  • True parathyroid adenomas are rare in tertiary hyperparathyroidism, occurring in only about 5% of cases 5

  • Diffuse, moderately enlarged hyperplastic glands are found predominantly in transplant patients, while nodular, markedly enlarged hyperplastic parathyroids are observed more frequently in patients treated by dialysis 5

Clinical Significance

  • The main indication for treatment is persistent hypercalcemia and/or increased PTH levels 2

  • Surgical excision (parathyroidectomy) is recommended for medically refractory cases 1

  • As tertiary hyperparathyroidism typically involves multigland disease (parathyroid hyperplasia), preoperative imaging aims to identify all eutopic and potential ectopic or supernumerary glands to guide the surgical approach 1

Treatment Options

  • Three surgical procedures are commonly performed: total parathyroidectomy with or without autotransplantation, subtotal parathyroidectomy, and limited parathyroidectomy 2

  • It is important to remove superior parts of the thymus during surgery as well 2

  • The optimal surgical approach remains controversial, with limited data available from only a few small trials with short follow-up 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tertiary hyperparathyroidism: a review.

La Clinica terapeutica, 2021

Research

Secondary and tertiary hyperparathyroidism.

Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry, 2013

Research

Laboratory screening for hyperparathyroidism.

Clinica chimica acta; international journal of clinical chemistry, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.